HAS opinions and decisions
La fiche de bon usage du médicament intitulée « Xolair (omalizumab) dans le traitement de l’asthme sévère», ci-jointe, est adoptée.
See also
HAS opinions and decisions
17/11/2017
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
Fm8Qw8VdMTD1mfEa